Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05186311 · ClinicalTrials.gov registry record

BD MiniDraw™ Capillary System Clinical Equivalence Study

A clinical trial of Healthy and Acute Disease, sponsored by Becton, Dickinson and Company.

Completed
Registry status
262
Enrollment target
1
Study location

NCT05186311: Completed study of Healthy and Acute Disease, sponsored by Becton, Dickinson and Company.

NCT05186311 is a study of Healthy and Acute Disease that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 262 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05186311, a study of Healthy and Acute Disease, has completed, sponsored by Becton, Dickinson and Company.

COMPLETED
Registry status
262 participants
Enrollment target
1
Study location

Study Summary

This study designed to evaluate the safety and effectiveness of a newly developed sample collection device. Participants will be enrolled and samples will be collected by representative future users of the device. Comparator venous and conventional capillary tubes will be collected by skilled healthcare professionals with phlebotomy experience. Samples will be tested and average differences between the investigational device compared to a marketed comparator will be evaluated. Visual observations will be captured and device safety will be assessed.

Primary Outcome

To demonstrate clinical equivalence of the SST test device as compared to Venous Comparator Serum and Capillary Comparator for chemistry analytes. This comparison was focused on the analytes with a unit of g/dL

Conditions Studied

Healthy Acute Disease Sample Collection Disease, Chronic

Interventions

  • DEVICE Capillary Blood Collection System

Study Locations (1)

Texas

  • Babson Diagnostics - Austin

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2022-04-22
Est. Completion 2022-10-24
Becton, Dickinson and Company

33 total trials

What the finished NCT05186311 record still lists

NCT05186311 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower).

The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Capillary Blood Collection System is the first listed.

NCT05186311 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05186311 about?

NCT05186311 is a clinical study titled "BD MiniDraw™ Capillary System Clinical Equivalence Study". This study designed to evaluate the safety and effectiveness of a newly developed sample collection device. Participants will be enrolled and samples will be collected by representative future users of the device. Comparator venous and conventional capillary tubes will be collected by skilled health...

What is the current status of trial NCT05186311?

This trial is currently completed. The enrollment target is 262 participants. The study started on 2022-04-22. Estimated completion is 2022-10-24.

What conditions does trial NCT05186311 study?

This clinical trial studies the following conditions: Healthy, Acute Disease, Sample Collection, Disease, Chronic.

What interventions are being tested in trial NCT05186311?

The interventions under investigation include: Capillary Blood Collection System (DEVICE).

Who is sponsoring clinical trial NCT05186311?

This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05186311 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05186311's enrollment target sits among peer trials

262 94th of 1090 higher than 996 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06074380 · 262 participants · Phase 4

    Non Inferiority Trial Investigating Surfactants Administered Via MIST

  • NCT06293703 · 262 participants · NA

    Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

  • NCT06780137 · 262 participants · Phase 1

    A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • NCT04067336 · 263 participants · Phase 1

    First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05186311, the US trial registry maintained by the National Library of Medicine. NCT05186311 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.